Head-to-head · computed 2026-08-11
bmiMD vs Noom Med
bmiMD: bmiMD is a compounded GLP-1 telehealth platform notable for flat per-dose pricing — the rate stays the same whether you're at 2.5 mg or 15 mg — and one of the widest plan-tier menus in the market. Its $99/mo semaglutide and $139/mo tirzepatide on the twelve-month plan are the lowest annualized figures in the dataset for both molecules. Noom Med: Noom bundles its behavior program with medication access; compounded semaglutide lists at $199/month all-in.
Tirzepatide
| bmiMD | Noom Med | |
|---|---|---|
| All-in maintenance | $179/mo | $299/mo |
| Best plan rate | $139/mo | $299/mo |
| 12-month total | $1,668 | $3,588 |
| Status | Reported · 2026-07-14 | Reported · 2026-08-11 |
The arithmetic
On the figures our desk holds, bmiMD's $179 a month undercuts Noom Med's $299 by $120 a month at the 10 mg/wk maintenance basis — $1,440 across a year. bmiMD's figure is reported (captured 2026-07-14) and Noom Med's is reported (captured 2026-08-11); a status below 'verified' means our independent checkout capture is still pending, so treat the gap as the best current evidence rather than settled fact.
bmiMD's tirzepatide ladder runs $179 a month billed monthly, $159 a month on a three-month plan, $149 a month on a six-month plan, and $139 a month on a twelve-month plan. Noom Med's runs $299 a month billed monthly. On the twelve-month basis bmiMD's $1,668 beats Noom Med's $3,588 by $1,920 — with the winner's figure resting on a committed twelve-month plan, a structural difference that matters if you might stop early.
Semaglutide
| bmiMD | Noom Med | |
|---|---|---|
| All-in maintenance | $129/mo | $249/mo |
| Best plan rate | $99/mo | $249/mo |
| 12-month total | $1,188 | $2,988 |
| Status | Reported · 2026-07-14 | Reported · 2026-08-11 |
The arithmetic
On the figures our desk holds, bmiMD's $129 a month undercuts Noom Med's $249 by $120 a month at the 2.4 mg/wk maintenance basis — $1,440 across a year. bmiMD's figure is reported (captured 2026-07-14) and Noom Med's is reported (captured 2026-08-11); a status below 'verified' means our independent checkout capture is still pending, so treat the gap as the best current evidence rather than settled fact.
bmiMD's semaglutide ladder runs $129 a month billed monthly, $119 a month on a three-month plan, $109 a month on a six-month plan, and $99 a month on a twelve-month plan. Noom Med's runs $249 a month billed monthly. On the twelve-month basis bmiMD's $1,188 beats Noom Med's $2,988 by $1,800 — with the winner's figure resting on a committed twelve-month plan, a structural difference that matters if you might stop early.
Structure, side by side
bmiMD
- MembershipNone
- Dose policyFlat — same price at every dose, across all plan lengths
- CommitmentMonthly, 3-month, 6-month, or 12-month plans; price varies by term, not by dose
- CancellationPer provider terms; confirm cancellation policy at enrollment
- PharmacyNamed 503A pharmacy partner (specific pharmacy not publicly identified on pricin
Noom Med
- MembershipNone
- Dose policyFlat at published rate
- CommitmentProgram-based
- CancellationPer plan terms
- PharmacyPartner pharmacies
What our desk is watching on each
bmiMD: bmiMD's 12-month semaglutide plan at $99/mo is the lowest annualized sema figure in our dataset, beating NexLife's $119/mo and Oak's $133 m2m. Month-to-month sema at $129 also beats Oak's $133, making bmiMD the new m2m sema leader. Tirzepatide 12-month at $139 ties NexLife. Figures are reported status from RangeYourself's July 2026 first-party captures; our independent checkout is pending.
Noom Med: Basis correction on record: the $199 figure previously recorded reflects Noom's microdose tier, which caps at 0.6 mg and therefore fails this site's maintenance-dose comparison basis; the standard compounded tiers — $249/mo semaglutide, $299/mo GLP-1/GIP Plus (tirzepatide) — are the rankable figures. Microdose tiers ($179 semaglutide / $199 tirzepatide per Noom's July 27, 2026 pricing) exist for gentler entry. All plans bill quarterly, not monthly; the branded-medication track ($99/mo after a $149 first month, medication separate) is a different product. Compounded not available in all states per Noom's own materials.
Questions people ask
Is bmiMD or Noom Med cheaper in 2026?
The tirzepatide and semaglutide verdict blocks above give the computed answer at the maintenance basis, with the verification status of each figure; the short version is that whichever program's all-in monthly number is lower on this page is cheaper on the evidence we hold today, and both rows carry capture dates so you can judge freshness.
What does bmiMD vs Noom Med miss that checkout will show?
Taxes, state availability, current promotions, and any dose surcharge introduced after our capture date. Screenshot the order summary before paying — that capture, not any comparison page, is your contract.
Why do you compare at the maintenance dose instead of the starting dose?
Because starter pricing lasts one or two months and maintenance pricing lasts the rest of the year; comparing starts against maintenances is the single most common way GLP-1 comparisons mislead.
What do bmiMD and Noom Med cost over a full year of tirzepatide?
On the plans our database holds, a year of tirzepatide runs $1,668 at bmiMD and $3,588 at Noom Med — computed from each program's best published twelve-month route, with promotional figures labeled in the sections above and every number carrying its capture date.
Both records live in the normalized database; re-run the math yourself from the downloads. Full record pages: bmiMD · Noom Med. Official sites: bmiMD ↗ · Noom Med ↗. Nothing here is medical advice.